«Евразийской конгресс внутренней медицины»
Opening of the Conference
Welcome speech:
A. G. Arutyunov (Russia, Moscow), I. G. Nikitin (Russia, Moscow)
Plenary session "Comorbidities at the turn of 2021 and 2022"
- DOAC safety issues in elderly patients with AF
(sponsored by Bayer, not accredited for CME credits) - G. P. Arutyunov (Moscow, Russia)
- 20 months with COVID-19. Eurasian Register "ACTIV"
- A. G. Arutyunov (Moscow, Russia)
- Wrapping up 2021. New trends in CHF
- Petar Seferovic (Belgrade, Serbia)
- Asymptomatic hyperuricemia and comorbidity issues
- V. I. Mazurov (Saint Petersburg, Russia)
- CKD. Unified therapeutic diagnosis
- M. M. Batyushin (Rostov-on-Don, Russia)
- PATE and in situ thrombus, more frequent than expected
- Marco Cattaneo (Milan, Italy)
- COPD: changes of 2021, expectations of 2022
- Z. P. Aisanov (Moscow, Russia)
- Influenza vaccine prophylaxis as a tool for cardiovascular risk management
- I. G. Nikitin (Moscow, Russia)
- Evolution of prevention and etiotropic therapy of COVID-19
- D. S. Fomina (Moscow, Russia)
Panel discussion "Pro vs Contra"
The session is held only on the Russian version of the site (in Russian)
(sponsored by TEVA, not accredited for CME credits)
A cardiologist’s and GP’s perspective on controlling AH
Mozheyko M. E. (Yaroslavl), O. P. Rotar (Russia, Saint Petersburg)
Break
Special MEDIS session "Prediabetes in medical practice: pitfalls and white spots of carbohydrate metabolism disorder"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Merck, not accredited for CME credits)
Chairpersons:
A. G. Arutyunov (Russia, Moscow), E. N. Grineva (Russia, Saint Petersburg)
- What can the diagnosis of prediabetes mean?
- E. N. Grineva (Russia, Saint Petersburg)
- Complications of prediabetes: do not miss the right moment
- Yu. Sh. Khalimov (Russia, Saint Petersburg)
- Carbohydrate metabolism disorders in the COVID-19 era: What we can do for our patients
- A. Yu. Babenko (Russia, Saint Petersburg)
Break
Workshop "Psychological aspects of diet therapy in patients with prediabetes"
ZOOM
(in Russian)
Continuation of the MEDIS session
G. A. Manushakyan (Russia, Moscow), S. N. Sulim (Russia, Moscow)
https://us06web.zoom.us/j/82764760758?pwd=N0lPK1JLU0RJVlFWajloeE9zNzNjZz09
Break
Special MEDIS session "Cardiovascular mortality growth in the post-COVID period: from background causes to countermeasures"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Merck, not accredited for CME credits)
Chairperson:
G. P. Arutyunov (Russia, Moscow)
- COVID-19 and frequent cardiovascular pathologies: a hidden threat or exaggerated significance?
- G. P. Arutyunov (Russia, Moscow)
- Therapeutic algorithm for post-COVID patients with frequent CV pathology. EAIM expert board data
- A. G. Arutyunov (Russia, Moscow)
- Is correction of drug therapy for CVDs necessary after a COVID-19 infection?
- A. O. Konradi (Russia, Saint Petersburg)
Day 1 wrap up
Broadcast in Hall №1
Broadcast in Hall №1
Broadcast in Hall №1
Break
Symposium "Arterial hypertension therapy in the COVID-19 era: practicalities and expectations"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Sanofi, not accredited for CME credits)
Chairperson:
G. P. Arutyunov (Russia, Moscow)
- Current AH therapy in compliance with clinical guidelines of leading cardiology societies
- G. P. Arutyunov (Russia, Moscow)
- Role of diuretics in clinical guidelines and in practice: myths and facts
- S. R. Gilyarevsky (Russia, Moscow)
- Fixed combinations with a calcium antagonist: what should guide your choice?
- S. V. Nedogoda (Russia, Volgograd)
Break
Symposium "Diabetes mellitus and IHD are two epidemics of our time. What therapy is needed when they are combined"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Bayer, not accredited for CME credits)
Chairperson:
G. P. Arutyunov (Russia, Moscow)
- How to improve prognosis in a patient with IHD and diabetes mellitus
- G. P. Arutyunov (Russia, Moscow)
- Is antiaggregant therapy sufficient to treat patients with high risk of cardiovascular events?
- A. G. Obrezan (Russia, Saint Petersburg)
- Evidence base for anticoagulants in treatment of patients with a combination of IHD and DM
- N. B. Perepech (Russia, Saint Petersburg)
- Can treatment outcomes be improved in patients with IHD and diabetic nephropathy?
- N. A. Koziolova (Russia, Perm)
- Multifocal atherosclerosis in diabetic patients. What to look out for?
- E. M. Nifontov (Russia, Saint Petersburg)
- A patient with IHD and diabetes mellitus. Consequences of suboptimal control
- G. R. Galstyan (Russia, Moscow)
Break
Workshop "Working with Weight Loss"
ZOOM
G. A. Manushakyan (Russia, Moscow), O. S. Fedorova (Russia, Moscow)
https://us06web.zoom.us/j/82764760758?pwd=N0lPK1JLU0RJVlFWajloeE9zNzNjZz09
Day 1 wrap up
Broadcast in Hall №1
Broadcast in Hall №1
Broadcast in Hall №1
Break
Symposium "Sleep disorders in the GP's practice"
Chairperson:
A. L. Kalinkin (Russia, Moscow)
- Function of sleep
- A. L. Kalinkin (Russia, Moscow), I. N. Pigarev (Russia, Moscow)
- Restless sleep disorder in children
- Lourdes DelRosso (Washington)
- Resistant arterial hypertension and OSAS
- Yu. V. Sviryaev (Russia, Saint Petersburg)
- Sleep disorders - unaccounted risk factors in GP's practice
- A. L. Kalinkin (Russia, Moscow)
Break
Symposium "Thrombosis in the practice of general practitioners and cardiologists"
Chairperson:
A. S. Galyavich (Russia, Kazan)
- Thrombosis: from etiopathogenesis to treatment
- A. S. Galyavich (Russia, Kazan)
- Intracardiac thrombosis. Clinical review
- Z. M. Galeyeva (Russia, Kazan)
- Antithrombotic treatment in diabetes mellitus
- L. V. Baleyeva (Russia, Kazan)
- Antithrombotic treatment after COVID-19
- G. M. Kamalov (Russia, Kazan)
- Closing remarks
- A. S. Galyavich (Russia, Kazan)
Break
Workshop "Working with Weight Loss"
ZOOM
G. A. Manushakyan (Russia, Moscow), O. S. Fedorova (Russia, Moscow)
https://us06web.zoom.us/j/82764760758?pwd=N0lPK1JLU0RJVlFWajloeE9zNzNjZz09
Symposium "Comorbid ACS patient: clinical review and choice of optimal therapy"
The session is held only on the Russian version of the site (in Russian)
Chairperson:
Yu. A. Karpov (Russia, Moscow)
- The use of antiplatelet agents in ACS: the latest scientific evidence of 2021
- N. A. Koziolova (Russia, Perm)
- Options for intensifying lipid-lowering therapy: can we reach the target of 1.4 mmol/l?
- Yu. A. Karpov (Russia, Moscow)
- Features of antihypertensive therapy in a patient with comorbid pathology
- O. A. Kislyak (Russia, Moscow)
Day 1 wrap up
Broadcast in Hall №1
Broadcast in Hall №1
Broadcast in Hall №1
Break
Symposium "New reality: patients with arterial hypertension and visceral obesity in the post-COVID period"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Stada, not accredited for CME credits)
Chairperson:
Zh. D. Kobalava (Russia, Moscow)
- Arterial hypertension: 2021 hot discussion topics
- Zh. D. Kobalava (Russia, Moscow)
- Nuances of 24-hour blood pressure monitoring in the post-COVID period
- A. G. Arutyunov (Russia, Moscow)
- Relevance and complexity of 24-hour BP control in patients with AH and visceral obesity
- Y. A. Karpov (Moscow)
Break
Symposium "Current issues in digestive pathology"
Chairperson:
I. G. Bakulin (Russia, Saint Petersburg)
- A new paradigm for the pathogenesis of digestive diseases
- I. V. Maev (Russia, Moscow)
- Inflammatory bowel disease: current issues
- I. G. Bakulin (Russia, Saint Petersburg)
- Antibiotic-associated diarrhea: current approaches to diagnostics and treatment
- N. V. Bakulina (Russia, Saint Petersburg)
- Gut microbiota: do we know everything about the pathogenesis of digestive diseases?
- E. B. Avalueva (Russia, Saint Petersburg)
- Liver pathology in a new coronavirus infection: a gastroenterologist's view
- E. V. Skazyvaeva (Russia, Saint Petersburg)
Break
Workshop "Working with Weight Loss"
ZOOM
G. A. Manushakyan (Russia, Moscow), O. S. Fedorova (Russia, Moscow)
https://us06web.zoom.us/j/82764760758?pwd=N0lPK1JLU0RJVlFWajloeE9zNzNjZz09
Day 1 wrap up
Broadcast in Hall №1
Broadcast in Hall №1
Broadcast in Hall №1
Break
Symposium "What do experts discuss? Cardiologists debate on comorbid patients with cardiovascular disease"
The session is held only on the Russian version of the site (in Russian)
(sponsored by TEVA, not accredited for CME credits)
Chairperson:
Yu. A. Karpov (Russia, Moscow)
- Comorbid patients with cardiovascular disease: who are they?
- S. V. Nedogoda (Russia, Volgograd)
- CVD therapy in the new reality. Is there a need for change?
- S. K. Zyryanov (Russia, Moscow)
Panel discussion
Panel discussion
Break
Symposium "Results of new prospective clinical trials"
Chairperson:
O. S. Fedorova (Russia, Moscow)
- Use of olokizumab in patients with a new coronavirus infection
- S. V. Topolyanskaya (Russia, Moscow)
- Reducing the risk of neurocognitive impairment in cardiac patients who underwent cardiopulmonary bypass surgery
- I. Yu. Chigareva (Russia, Moscow)
- Effect of combined glucose-normalising therapy on the structural and functional status of the heart in type 2 diabetic patients
- V. R. Miminoshvili (Ukraine, Donetsk)
- Prognostic value of the CLIF-C scale for a group of hospitalized patients with cirrhosis
- D. I. Gavrilenko (Belarus, Minsk)
- Features of the clinical course of post-COVID syndrome in comorbid patients with rheumatoid arthritis in clinical practice
- L. E. Sarantseva (Russia, Saint Petersburg)
- Efficacy of pharmacotherapy in patients with non-alcoholic fatty liver disease combined with arterial hypertension and type 2 diabetes mellitus
- I. A. Lukonin (Russia, Krasnodar)
- Development of Takotsubo syndrome in patients with COVID-19
- Kolodyazhnaya O. I. (Russia, Moscow)
Break
Workshop "Working with Weight Loss"
ZOOM
G. A. Manushakyan (Russia, Moscow), O. S. Fedorova (Russia, Moscow)
https://us06web.zoom.us/j/82764760758?pwd=N0lPK1JLU0RJVlFWajloeE9zNzNjZz09
Day 1 wrap up
Broadcast in Hall №1
Broadcast in Hall №1
Broadcast in Hall №1
Break
Symposium "An update in metabolic and reproductive endocrinology"
Chairpersons:
Djuro Macut (Serbia, Belgrade), Goran Cvijovic (Serbia, Belgrade)
- Gestational diabetes mellitus: an endocrine approach
- Djuro Macut (Serbia, Belgrade)
- Metabolic and reproductive effects of melatonin therapy
- Goran Cvijovic (Serbia, Belgrade)
- Is every woman with polycystic ovary syndrome at risk to develop type 2 diabetes?
- Sarantis Livadas (Greece, Athens)
- Metabolic surgery: is it just about insulin resistance control?
- Jose Silva Nunes (Portugal, Lisbon)
Break
Symposium "Cardiovascular risk management in clinical practice"
Chairpersons:
A. B. Sugraliev (Kazakhstan, Almaty), Sh. B. Zhangelova (Kazakhstan, Almaty)
- Type 2 diabetes mellitus. Cardiovascular risk management
- B. K. Zholdin (Kazakhstan, Aktobe)
- Assessment and management of risk factors in patients with CIHD
- Sh. B. Zhangelova (Kazakhstan, Almaty)
- Assessment and management of risk factors in patients with AH
- V. A. Zhakipbekova (Kazakhstan, Karaganda)
- Risk factors and issues of primary and secondary prevention of venous thrombosis in general practice
- A. B. Sugraliev (Kazakhstan, Almaty)
Break
Workshop "Working with Weight Loss"
ZOOM
G. A. Manushakyan (Russia, Moscow), O. S. Fedorova (Russia, Moscow)
https://us06web.zoom.us/j/82764760758?pwd=N0lPK1JLU0RJVlFWajloeE9zNzNjZz09
Day 1 wrap up
Symposium "Dyslipidemia - a turning point in history"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Abbot Laboratories OOO, not accredited for CME credits)
Chairperson:
G. P. Arutyunov (Russia, Moscow)
- The key to unlock the era of combination therapy
- G. P. Arutyunov (Russia, Moscow)
- Combination therapy in lipidology: residual risk correction
- A. S. Alieva (Russia, Saint Petersburg)
- The role of fixed combination in the therapy of patients with dyslipidemia
- A. G. Obrezan (Russia, Saint Petersburg)
- Omega-3 PUFAs in the secondary prevention of myocardial infarction in patients with chronic heart failure. It is useless to say: "We do everything we can"
- N. A. Koziolova (Russia, Perm)
- Panel discussion
- G. P. Arutyunov (Russia, Moscow)
Break
Speed session "Life and health of an elderly patient with AF and high risk of bleeding"
(sponsored by Bayer, not accredited for CME credits)
- Why is a comprehensive approach important for the elderly patient with AF?
- S. V. Villevalde (Russia, Saint Petersburg)
- Protecting elderly patients with AF from stroke. What is always important to remember?
- G. P. Arutyunov (Russia, Moscow)
- Therapy safety is a significant component of comprehensive protection for the AF patient
- A. G. Arutyunov (Russia, Moscow)
- Nephrologist's opinion on the use of anticoagulants in patients with AF and renal dysfunction
- M. M. Batyushin (Russia, Rostov-on-Don)
- Protecting kidney function - can the risk of worsening kidney function in patients with AF be reduced?
- N. A. Koziolova (Russia, Perm)
- What do coronary risks mean for a patient with AF: what to expect and how to avoid severe consequences?
- A. N. Yakovlev (Russia, Saint Petersburg)
- Compliance with therapy is the key to the therapy reliability
- S. S. Kucherenko (Russia, Saint Petersburg)
- Annoying bleedings on DOAC therapy in patients with AF: what is to be done?
- E. I. Tarlovskaya (Russia, Nizhny Novgorod)
- GI bleeding and DOAC therapy. Are they interconnected?
- N. V. Bakulina (Russia, Saint Petersburg)
Panel discussion of relevant topics
Experts:
S. V. Villevalde (Russia, Saint Petersburg), G. P. Arutyunov (Russia, Moscow), A. G. Arutyunov (Russia, Moscow), M. M. Batyushin (Russia, Rostov-on-Don), N. A. Koziolova (Russia, Perm), A. N. Yakovlev (Russia, Saint Petersburg), S. S. Kucherenko (Russia, Saint Petersburg), E. I. Tarlovskaya (Russia, Nizhny Novgorod), N. V. Bakulina (Russia, Saint Petersburg)
Dedicated Zoom rooms
Q&A SESSION
S. V. Villevalde (Russia, Saint Petersburg), G. P. Arutyunov (Russia, Moscow), A. G. Arutyunov (Russia, Moscow), M. M. Batyushin (Russia, Rostov-on-Don), N. A. Koziolova (Russia, Perm), A. N. Yakovlev (Russia, Saint Petersburg), S. S. Kucherenko (Russia, Saint Petersburg), E. I. Tarlovskaya (Russia, Nizhny Novgorod), N. V. Bakulina (Russia, Saint Petersburg)
Break
Symposium "A new world and new rules for the management of patients with AH"
The session is held only on the Russian version of the site (in Russian)
(sponsored by TEVA, not accredited for CME credits)
Chairperson:
G. P. Arutyunov (Russia, Moscow)
- Time for change. Challenges in the therapy of AH patients
- N. A. Koziolova (Russia, Perm)
- AH in 2021. Let's dot the i's and cross the t's after the ESC Congress
- E. V. Privalova (Russia. Moscow)
Break
The future of modern medicine
- Diabetes is a global pandemic. Trends and expectations for the next 5 years
- V. V. Salukhov (Russia, Saint Petersburg)
- Artificial intelligence in assessing the severity of a new coronavirus infection course
- N. Yu. Grigoryeva (Russia, Nizhny Novgorod)
- What to expect in the treatment of CHF over the next 5 years
- I. I. Shaposhnik (Russia, Chelyabinsk)
Day 2 wrap up
Symposium "Vestibular vertigo. Practical approaches"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Berlin-Chemie, not accredited for CME credits)
Chairperson:
V. A. Parfenov (Russia, Moscow)
- Vestibular vertigo: diagnosis and treatment, common diagnostic errors. Vestibular neuronitis
- V. A. Parfenov (Russia, Moscow)
- Unmanageable vertigo in internist practice
- N. A. Koziolova (Russia, Perm)
- Meniere's disease. Differential diagnosis and treatment approaches
- A. L. Guseva (Russia, Moscow)
Break
Broadcast in Hall №1
Break
Symposium "Post-COVID: expected complications"
Chairperson:
A. G. Arutyunov (Russia, Moscow)
- How long do antibodies persist after COVID-19?
- V. V. Shustov (Russia, Moscow)
- Long-term COVID-19 consequences
- A. G. Arutyunov (Russia, Moscow)
- CHF in the post-COVID period
- Bojan Vrtovec (Slovenia, Ljubljana)
- Post-COVID as a new risk category
- Goran Krstačić (Croatia, Zagreb)
- CKD in the post-COVID period
- M. M. Batyushin (Russia, Rostov-on-Don)
Break
Broadcast in Hall №1
Day 2 wrap up
Symposium "The COVID-19 pandemic: continuing to learn lessons"
Chairperson:
E. I. Tarlovskaya (Russia, Nizhny Novgorod)
- Effect of clusters of comorbidities on the severity of the course of new coronavirus infection: International Registry Analysis of Comorbid Disease Dynamics in Patients after SARSCoV-2 Infection (ACTIV)
- E. I. Tarlovskaya (Russia, Nizhny Novgorod)
- Choosing an effective target therapy window with Olokizumab
(sponsored by R-Pharm, not accredited for CME credits) - A. G. Arutyunov (Russia, Moscow)
- Recommendations for the follow-up of CHF patients after COVID-19
- A. I. Chesnikova (Russia, Rostov-on-Don)
- Experience of rehabilitation of patients after COVID-19
- M. V. Boldina (Russia, Nizhny Novgorod)
Break
Broadcast in Hall №1
Break
Symposium "Complex and unresolved issues in the management of patients with respiratory pathology and cardiovascular diseases"
Chairperson:
E. I. Tarlovskaya (Russia, Nizhny Novgorod)
- Cardiovascular disease in patients with COPD: breaking stereotypes, following guidelines
- A. I. Chesnikova (Russia, Rostov-on-Don)
- Tactics for antianginal therapy in patients with IHD concomitant with bronchial asthma
- N. Yu. Grigoryeva (Russia, Nizhny Novgorod)
- Nuances of the management of patients with bronchial asthma and cardiovascular diseases
- M. V. Boldina (Russia, Nizhny Novgorod)
- Effect of drugs used to treat cardiac diseases on the severity of the course of respiratory viral infections
- E. I. Tarlovskaya (Russia, Nizhny Novgorod)
Break
Broadcast in Hall №1
Day 2 wrap up
Symposium "Modern antibiotic therapy: about COVID-19 and beyond"
Chairperson:
S. K. Zyryanov (Russia, Moscow)
- Contribution of the pandemic to antibiotic resistance. Emphasis on a broad spectrum
- A. O. Bykov (Russia, Moscow)
- Pregnancy and medication. Dosing for two?
- E. A. Ushkalova (Russia, Moscow)
- A patient with altered renal and hepatic function. What is important to consider?
- O. I. Butranova (Russia, Moscow)
- An elderly patient: nuances of antibiotic therapy
- S. K. Zyryanov (Russia, Moscow)
Break
Broadcast in Hall №1
Break
Symposium "Osteoporosis in clinical practice. Clinical review"
Chairperson:
O. M. Lesniak (Russia, Saint Petersburg)
- Welcome speech
- O. M. Lesniak (Russia, Saint Petersburg)
- Compression fractures of vertebral bodies in GP’s practice
- L. P. Evstigneeva (Russia, Ekaterinburg)
- Vitamin D deficiency in osteoporosis and beyond
- T. L. Karonova (Russia, Saint Petersburg)
- Differential diagnosis of osteoporosis with other metabolic skeletal diseases
- O. M. Lesniak (Russia, Saint Petersburg)
- How to prevent repeated fractures due to osteoporosis
- O. B. Ershova (Russia, Yaroslavl)
Break
Broadcast in Hall №1
Day 2 wrap up
Symposium of the Republic of Belarus "Difficult clinical cases"
Chairperson:
N. P. Mitkovskaya (Belarus, Minsk)
- The craftiness of infective endocarditis
- N. P. Mitkovskaya (Belarus, Minsk)
- Deep vein thrombosis in a comorbid patient
- G. P. Arutyunov (Russia, Moscow)
- Caseous calcification of the mitral valve
- E. A. Grigorenko (Belarus, Minsk)
- Clinical case of simultaneous endovascular embolization of a coronary pulmonary fistula and stenting of an extended stenosis of the anterior interventricular artery in a patient with stable angina
- O. L. Polonetskiy (Belarus, Minsk)
- Patient with chronic heart failure, left bundle branch block, severe mitral regurgitation: where to start?
- D. B. Goncharik (Belarus, Minsk)
Break
Broadcast in Hall №1
Break
Symposium of Armenian Association of Internal Medicine
Chairperson:
L. A. Manukyan (Armenia, Yerevan)
- Caring for the elderly with dementia. UK experience
- Seda Boghossian-Tighe (England, Walton-on-Thames)
- Bronchial asthma: problems and solutions
- M. R. Oganyan (Armenia, Yerevan)
- Correction of endothelial dysfunction and metabolic disorders in the post-COVID period
- L. A. Manukyan (Armenia, Yerevan)
Break
Broadcast in Hall №1
Day 2 wrap up
Symposium "Unified cardiovascular and metabolic approach to treatment of patients with obesity and diabetes mellitus"
(sponsored by Novo Nordisk, not accredited for CME credits)
Chairpersons:
G. A. Manushakyan (Moscow, Russia), A. G. Arutyunov (Moscow, Russia)
- New vision of patients with metabolic disoders: when medication should be initiated?
- A. G. Arutyunov (Moscow, Russia)
- Outside of glycaemia control: perspectives of therapy with GLP-1 agonists in patients with diabetes mellitus type 2
- E. A. Shestakova (Moscow, Russia)
- Drug therapy of obesity: earlier initiation makes better progress
- N. A. Matsiyevsky (St. Ptersburg, Russia)
- From theory to practice: personalized choice of GLP-1 agonists in wide range of clinical cases
- G. A. Manushakyan (Moscow, Russia)
Symposium "Treating Heart Failure: Time to Seize New Opportunities"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Boehringer Ingelheim, not accredited for CME credits)
Chairperson:
Yu. M. Lopatin (Russia, Volgograd)
- New algorithm for treatment of heart failure with reduced ejection fraction - how cardiologist can incorporate modern approaches into clinical practice?
- S. V. Nedogoda (Russia, Volgograd)
- Empagliflozin in patients with HF across the ejection fraction spectrum - pooled data of the EMPEROR trial
- G. P. Arutyunov (Russia, Moscow)
- Diabetes mellitus type 2 and heart failure: there is still something to strive for an endocrinologist and a cardiologist
- V. V. Salukhov (Russia, Saint Petersburg)
Break
Speed session "Treating heart failure: it is not as simple as it seems"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Boehringer Ingelheim, not accredited for CME credits)
- Main results of the EMPEROR-Preserved trial
- Stefan D. Anker (Germany, Berlin)
- Main mechanisms of SGLT2 inhibitors impact on heart failure outcomes
- Yu. Sh. Khalimov (Russia, Saint Petersburg)
- Nephroprotective effects of SGLT2 inhibitors in heart failure
- Janaka Karalliedde (England, London)
- Safety of SGLT2 inhibitors in patients without type 2 diabetes
- I. V. Zhirov (Russia, Moscow)
- A universal definition and a new classification of heart failure
- S. V. Nedogoda (Russia, Volgograd)
- Optimising therapy for heart failure depending on a patient profile
- G. P. Arutyunov (Russia, Moscow)
- New European algorithms for the treatment of heart failure
- Yu. M. Lopatin (Russia, Volgograd)
Panel discussion of relevant topics
The session is held only on the Russian version of the site (in Russian)
Experts:
Stefan D. Anker (Germany, Berlin), Yu. Sh. Khalimov (Russia, Saint Petersburg), Janaka Karalliedde (England, London), I. V. Zhirov (Russia, Moscow), S. V. Nedogoda (Russia, Volgograd), G. P. Arutyunov (Russia, Moscow), Yu. M. Lopatin (Russia, Volgograd)
Break
Symposium "Features of a vulnerable patient population with heart failure with normal ejection fraction (HFNEF) after a decompensation episode: opportunities to correct the disease trajectory"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Bayer, not accredited for CME credits)
Chairperson:
Yu. M. Lopatin (Russia, Volgograd)
- A decompensation episode of HFNEF is a turning point in the clinical course of the disease
- A. G. Arutyunov (Russia, Moscow)
- Clinical practice challenges in reducing the residual risk of recurrent events
- S. R. Gilyarevsky (Moscow)
- Pathophysiological significance of soluble guanylate cyclase (sGC) as a potential therapeutic target in HFNEF
- Zh. D. Kobalova (Russia, Moscow)
- Prospects for improved prognosis after an episode of decompensated HF in the light of the VICTORIA trial results
- Yu. M. Lopatin (Russia, Volgograd)
- Discussion/Closing remarks
Wrap up of the Congress
Symposium "Innovative Approach to Cardiovascular Risk Stratification in Outpatient Practice"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Abbott Laboratories LLC, not accredited for CME credits)
Chairperson:
A. G. Arutyunov (Russia, Moscow)
- Biomarkers as predictors of cardiovascular risk
- G. P. Arutyunov (Russia, Moscow)
- New potential of high-sensitivity troponin-I according to domestic research
- A. V. Kontsevaya (Russia, Moscow)
- The role of high-sensitivity troponin-I in the management of cardiovascular risk in patients. Croatia's experience
- Goran Krstacic (Croatia, Zagreb)
- High-sensitivity troponin-I in patients with chronic cardiovascular diseases
- N. A. Koziolova (Russia, Perm)
- Panel discussion
- A. G. Arutyunov (Russia, Moscow)
Break
Broadcast in Hall №1
Break
Symposium "Cardiovascular therapy: scientific advances and clinical practice"
The session is held only on the Russian version of the site (in Russian)
(sponsored by Berlin-Chemie, not accredited for CME credits)
Chairperson:
V. S. Gurevich (Russia, Saint Petersburg)
- The role of organ protection in the treatment of an AH patient
- V. S. Gurevich (Russia, Saint Petersburg)
- Stable angina: from clinical guidelines to clinical practice
- E. I. Baranova (Russia, Saint Petersburg)
- Beta-blockers in the treatment of elderly patients: an assessment of current attitudes and therapeutic options
- A. P. Rebrov (Russia, Saratov)
Wrap up of the Congress
Symposium "From AH to CHF - changing treatment regimens"
Chairperson:
I. S. Yavelov (Russia, Moscow)
- PATE in patients with CHF before and after COVID-19
- I. S. Yavelov (Russia, Moscow)
- Disease-modifying therapy as a main new principle of CHF treatment
- I. V. Zhirov (Russia, Moscow)
- AH therapy: how to prevent CHF development. New opportunities
(sponsored by Novartis, not accredited for CME credits) - T. N. Novikova (Russia, Saint Petersburg)
Break
Broadcast in Hall №1
Break
Symposium "Thyroid diseases"
Chairpersons:
O. S. Fedorova (Russia, Moscow), A. R. Volkova (Russia, Saint Petersburg)
- Subclinical hypothyroidism: to treat or not to treat
- E. M. Patrakeyeva (Russia, Saint Petersburg)
- The vicious circle of thyroid metabolism in patients with CKD
- A. R. Volkova (Russia, Saint Petersburg)
- Nodular goiter in questions and answers. Current approaches to diagnostics and treatment
- O. S. Fedorova (Russia, Moscow)
- Monitoring of patients with operated thyroid gland
- O. A. Nechaeva (Russia, Moscow)
Wrap up of the Congress
Symposium "Current Issues in Nephrology - Facing the General Practitioner"
Chairperson:
M. M. Batyushin (Russia, Rostov-on-Don)
- Dietary salt intake and CKD, is arterial hypertension the only link?
- Tatsuo Shimosawa (Japan, Tokyo)
- Acute kidney injury in CHF
- M. M. Batyushin (Russia, Rostov-on-Don)
- Risk factors of diabetic nephropathy progression: it is not about hyperglycemia
- Janaka Karalliedde (England, London)
Break
Broadcast in Hall №1
Break
Symposium "New opportunities to influence remodeling processes at different stages of the cardiovascular continuum"
(sponsored by Novartis, not accredited for CME credits)
Chairpersons:
G. P. Arutyunov (Russia, Moscow), V. V. Tyrenko (Russia, Saint Petersburg)
- The natriuretic peptide system: physiological role. Involvement in the pathogenesis of AH and CHF. Application points in pharmacotherapy
- V. N. Khirmanov (Russia, Saint Petersburg)
- Class of angiotensin receptor-neprilysin inhibitors (ARNIs). New AH therapy options
- G. P. Arutyunov (Russia, Moscow)
- The ARNI class in de novo patients with CHF: the earlier, the better
- V. V. Tyrenko (Russia, Saint Petersburg)
Wrap up of the Congress
Symposium "New insights in Cardiovascular Medicine"
Chairperson:
Plinio Cirillo (Naples, Italy)
- Molecular therapies and models for cardiovascular disease
- Francesco Loffredo (Trieste, Italy)
- The emerging role of non conventional risk factors in cardiovascular disease
- Plinio Cirillo (Naples, Italy)
- Colchicine and cardiovascular disease: the second youth of an "old" drug
- Giovanni Cimmino (Naples, Italy)
- Non angiographically significant coronary stenosis: to treat or not to treat? The role of Fractional Flow Reserve to guide coronary revascularization
- Luigi Di Serafino (Naples, Italy)
Break
Broadcast in Hall №1
Break
Symposium "Results of new prospective clinical trials"
Chairperson:
G. A. Manushakyan (Russia, Moscow)
- Glycaemic profile in patients with new coronavirus infection COVID-19
- S. V. Perepelitsa (Russia, Kaliningrad)
- Features of the expanded cytokine profile in patients with COVID-19
- E. V. Koroleva (Russia, Nizhny Novgorod)
- COPD with frequent severe exacerbations: the role of comorbid pathology
- A. R. Zinnatullina (Russia, Kazan)
- Acute-to-chronic liver failure syndrome: applicability of a new model in clinical practice
- D. I. Gavrilenko (Belarus, Minsk)
- COVID-19-associated structural and functional heart changes in elderly patients
- L. A. Bodretskaya, I. S. Shapovalenko, I. A. Antonyuk-Shcheglova, E. V. Bondarenko, S. S. Naskalova, V. B. Shatilo (Ukraine, Kiev)
- Clinical features in patients with myocardial infarction and diabetic nephropathy carrying the polymorphic variants of NOS3, APOE and SLCO1B1
- A. V. Siverina (Russia, Saint Petersburg)
- Dynamic assessment of heart rate variability in physically trained individuals
- I. I. Novikov (Russia, Saint Petersburg)
Wrap up of the Congress
Partners
During the conference days all the participants can visit online medical expo, contact representatives of the companies and get electronic info materials.
Platinum partner
Special partner
Main partner
Golden partner
Golden partner
Silver partner
Silver partner
Silver partner
Silver partner
Partner
About the conference
Health care professionals are invited to participate in the Eurasian Congress of Internal Medicine
held under the auspices of the Ministry of Health of the Russian Federation
Key topics:
- Treatment Challenges in Comorbidities: Specifics of Post-COVID Management of Patients
- Nephrology for General Practitioners: focus on Acute Kidney Injury and Chronic Kidney Disease
- Issues in prescribing antibiotic therapy in view of increasing antimicrobial resistance. Current perspective on the problem.
- The problem of COPD within the internal medicine clinic. Expectations and changes
- CHF: New Treatment Trends and Approaches. Patient Prognosis Evaluation: how to Improve Quality of Life
- Endocrinology Today: Focus on Type 2 Diabetes and Thyroid Pathology. Diagnostics and Current Evidence-Based Treatment Strategies
- Cardiovascular risk management in real clinical practice
Speakers
About the Association
The Eurasian Association of Therapists is an independent association that provides an opportunity for its members to share experience and discuss crucial problems of evidence-based medicine and clinical practice.
Among the Association’s main goals is to disseminate information about ground-breaking research in the field of internal medicine.
The Association holds free events for medical specialists letting them earn CME credit points.
Medical specialists may become members of the EAT’s expert community and get access to more materials on the Association’s website
Go to the website euat.ruFAQ
This event is organized for medical professionals: practicing physicians, residents, medical students.
Participation is free.
Any specialist of the internal medicine can take part in the competition. Compliance with the requirements for participants and submission procedures is obligatory. See more information about the requirements in "Submission" section.
The broadcast can be viewed on this website; it will be available on the day of the conference – (September 29 – October 1, 2021).
Past events
Watch recordings of past events of the Eurasian Association of Internal Medicine